Articles by Eluemuno R. Blyden, PhD - BioPharm International

ADVERTISEMENT

ADVERTISEMENT

Articles by Eluemuno R. Blyden, PhD

New Approaches to Improved Vaccine Manufacturing in Embryonated Eggs

Recombinant vector technologies can improve the yield and lower the cost of egg-based influenza vaccine production.
Jan 2, 2010

Recombinant vector technologies can improve the yield and lower the cost of egg-based influenza vaccine production.

ADVERTISEMENT

ADVERTISEMENT

Click here